Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 42Terminated 16Unknown 15Recruiting 10Not yet recruiting 9Active not recruiting 9Withdrawn 3Suspended 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Genitourinary 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Prostatic Neoplasms 1Peritoneal Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Mesothelioma 1Hepatoblastoma 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Chemotherapeutic Agent Toxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Etoposide 2Cisplatin 2Carboplatin 2durvalumab 1Radiosurgery 1Platinum 1Paclitaxel 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Small Cell Lung Carcinoma × Cisplatin × Clear all
NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

University of Maryland, Baltimore

Phase 1 Suspended
50 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡